Highlights and Quick Summary
- Depreciation & Amortization Growth for the quarter ending December 31, 2022 was -25.45% (a 32.35% increase compared to previous quarter)
- Year-over-year quarterly Depreciation & Amortization Growth increased by 31.19%
- Annual Depreciation & Amortization Growth for 2022 was -57.4% (a -182.35% decrease from previous year)
- Annual Depreciation & Amortization Growth for 2022 was 69.7% (a -253.12% decrease from previous year)
- Annual Depreciation & Amortization Growth for 2021 was -45.52% (a -136.96% decrease from previous year)
- Twelve month Depreciation & Amortization Growth ending December 31, 2022 was -36.73% (a 7.93% increase compared to previous quarter)
- Twelve month trailing Depreciation & Amortization Growth increased by 1240.51% year-over-year
Trailing Depreciation & Amortization Growth for the last four month:
31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
---|---|---|---|
-36.73% | -34.03% | -27.71% | -2.74% |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Depreciation & Amortization Growth of Benitec Biopharma Limited
Most recent Depreciation & Amortization Growthof BNTC including historical data for past 10 years.Interactive Chart of Depreciation & Amortization Growth of Benitec Biopharma Limited
Benitec Biopharma Limited Depreciation & Amortization Growth for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | -25.45% | -19.23% | -88.46% | -19.4% | -57.4% |
2021 | -17.91% | 15.56% | 30.0% | -55.33% | -45.52% |
2020 | -29.99% | -11.76% | -80.95% | 87.5% | -49.2% |
2019 | – | – | 857.0% | 70.0% | 0.0% |
2018 | – | – | – | – | 0.27% |
2017 | – | – | – | – | -22.49% |
2016 | – | – | – | 425.0% | 0.09% |
2015 | – | – | – | -46.67% | 588.14% |
2014 | – | – | – | -89.55% | -61.44% |
2013 | -41.18% | – | – | – | 159.32% |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology